Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02467270
Brief Title: Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses (OPTIC)

First Submitted : June 2, 2015
First Submitted that Met QC Criteria : June 5, 2015
First Posted : June 10, 2015 (Estimate)

Results First Submitted : April 14, 2021
Results First Submitted that Met QC Criteria : May 18, 2021
Results First Posted : June 14, 2021

Last Update Submitted that Met QC Criteria : January 4, 2022
Last Update Posted : January 13, 2022